Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.
Basic
5
Ṁ286
2030
35%
chance

If the FDA approves a pharmaceutical intervention for ME/CFS before 1st Jan 2030 this market shall resolve to yes. This does not include potential comorbidities, such as long covid.

Get
Ṁ1,000
and
S3.00
© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules